getbig bpc 157 BPC-157 BPC-157 | Peak Biosciences
Description
These modifications enhance stability and prolong biological activity, enable sustained receptor activation with less dosing frequency
A randomized, double-blind, phase II study of first-line FOLFOX plus bevacizumab with onartuzumab versus placebo in patients with metastatic colorectal cancer (mCRC)
2011;300:G621G626
Another study published in Journal of Neurotrauma reported that Dihexa administration enhanced nerve regeneration and functional recovery in a rat model of peripheral nerve injury
